Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Establishment Labs logo — company profile

Establishment Labs

Founded 2004 Costa Rica Costa Rica 858 employees Post-IPO Equity Total: $530.70M Biotechnology, Health Care +2

General Information

Company Name Establishment Labs
Founded Year 2004
Location Costa Rica Costa Rica
Founders / Decision Makers
Team member
Employees 858
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Establishment Labs. To contact Establishment Labs, visit establishmentlabs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Establishment Labs compare?

A PDF of Establishment Labs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Establishment Labs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Establishment Labs

Establishment Labs® is a global medical technology company that focuses on enhancing patient safety and aesthetic outcomes, primarily in the breast aesthetics and reconstruction market. The company's flagship product, Motiva Implants®, is a portfolio of silicone gel-filled breast implants designed, developed, manufactured, and marketed under the MotivaImagine® platform. These implants are produced at two FDA-compliant facilities in Costa Rica and have received commercial distribution approval in over 70 countries. In a significant development, in March 2018, Establishment Labs® obtained an investigational device exemption (IDE) from the FDA to commence clinical trials for Motiva Implants® in the United States. The company, founded in 2004, operates in the Biotechnology, Health Care, Manufacturing, and Medical Devices industries. Notably, it secured a $50.00M post-IPO equity investment on 9th January 2024, with the investment coming from RTW Investments and Nantahala Capital Management.

Business keywords: breast aesthetics, breast implants, patient safety, aesthetic outcomes, global company, silicone gel-filled implants, Motiva Implants, FDA approval, clinical trial, investigational device exemption, IDE, Costa Rica manufacturing facilities, global distribution, innovation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $50.00M 2
RTW Investments
RTW Investments, Nantahala Capital Management
09 Jan 2024
Post IPO Equity $78.70M -
24 Apr 2023
Post IPO Debt $225.00M 1
Oaktree Capital
Oaktree Capital
26 Apr 2022
Post IPO Equity $69.00M -
28 Jan 2020
Private Equity Round $55.00M 1
Madryn Asset Management
Madryn Asset Management
28 Aug 2017
Venture Round $18.00M 2
Kilowatt Capital LLC, Florence Capital Advisors
17 Apr 2017
Debt Financing $15.00M 2
JW Asset Management Perceptive Advisors
JW Asset Management, Perceptive Advisors
29 Sep 2016
Venture Round $20.00M 3
JW Asset Management Crown Predator Holdings
JW Asset Management, Crown Predator Holdings +1
17 Sep 2015

Establishment Labs Alternatives & Competitors

View All Alternatives
Establishment Labs vs
Empirical Spine, Inc
Empirical Spine, Inc United States

It’s time for a new surgical standard of care that provides spinal stabilization without compromisin...

Series B
9 employees
Health Care, Medical Devices
Establishment Labs vs
Avenu Medical
Avenu Medical United States

Avenu Medical is a well-established medical device company dedicated to creating a paradigm shift in...

Venture round
10 employees
Health Care, Medical Devices
Compare Establishment Labs vs Avenu Medical
Establishment Labs vs
Autem Therapeutics
Autem Therapeutics United States

EM-Powering Cancer Care

Series A
16 employees
Biotechnology, Health Care
Also compare with: Establishment Labs vs Crown Laboratories, Inc. Crown Laboratories, Inc. View all alternatives

FAQ About Establishment Labs

Establishment Labs® (NASDAQ:ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing, and marketing an innovative portfolio of silicone gel-filled brea...
Establishment Labs was founded in 2004.
Establishment Labs is headquartered in Costa Rica.
Establishment Labs operates in Biotechnology, Health Care, Manufacturing and Medical Devices. Its work centres on breast aesthetics, breast implants, patient safety and aesthetic outcomes.
Establishment Labs has approximately 858 employees.
Establishment Labs has completed 8 funding rounds, raising a total of $530.70M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Establishment Labs include Empirical Spine, Inc, Avenu Medical, Autem Therapeutics, Crown Laboratories, Inc., Q3 Medical Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Establishment Labs and Empirical Spine, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Establishment Labs, https://bouncewatch.com/company/establishment-labs, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout